Ruxolitinib in combination with prednisone and nilotinib exhibit synergistic effects in human cells lines and primary cells from myeloproliferative neoplasmsAlicia Arenas Cortés, Joaquín Martínez‐López, Pilar Hernández-Campo et al.|Haematologica|2018Cited by 9